Dr Daniel Wiseman is an Honorary Consultant Haematologist at The Christie and a Clinician Scientist with a research group based at the CRUK Manchester Institute/Manchester Cancer Research Centre. He qualified in medicine from the University of Manchester in 2003 and completed general medical, then specialist haematology training at various hospitals in the North West of England, acceding to the Specialist Register in 2012. In 2016 he completed a PhD at the CRUK Manchester Institute, during which he researched the role of isocitrate dehydrogenase mutations in acute myeloid leukaemia.